Photo from wikipedia
In patients with type 2 diabetes who were inadequately controlled with metformin and sulphonylurea, we compared the glucose‐lowering efficacy, cardiometabolic parameters and safety of two drugs, ipragliflozin, a sodium‐glucose cotransporter‐2… Click to show full abstract
In patients with type 2 diabetes who were inadequately controlled with metformin and sulphonylurea, we compared the glucose‐lowering efficacy, cardiometabolic parameters and safety of two drugs, ipragliflozin, a sodium‐glucose cotransporter‐2 inhibitor, and sitagliptin, a dipeptidyl peptidase‐4 inhibitor.
Keywords:
sitagliptin;
ivs;
type diabetes;
vascular metabolic;
metformin;
metabolic effects
Journal Title: Diabetes
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Diabetes
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!